Breaking News Instant updates and real-time market news.

HIBB

Hibbett Sports

$21.66

3.62 (20.07%)

06:22
03/25/19
03/25
06:22
03/25/19
06:22

Hibbett Sports upgraded to Positive from Neutral at Susquehanna

HIBB Hibbett Sports
$21.66

3.62 (20.07%)

10/30/18
BARD
10/30/18
NO CHANGE
BARD
Hibbett Sports acquisition of City Gear bolsters urban presence, says Baird
Baird analyst Peter Benedict maintained a Neutral rating on Hibbet Sports. The analyst believes the planned acquisition of City Gear will bolster the company's presence among the younger fashion- forward customers in urban areas, and that the strategic rationale of the transaction makes sense as City Gear is expected to be accretive to EPS next year. However, the analyst also sees "stemming the decline in store comps and EBIT margins at the core-HIBB banner" as a key for the stock, and said visibility on that front was "still low."
03/14/19
BARD
03/14/19
NO CHANGE
Target $16
BARD
Neutral
Hibbett Sports Q4 comps upside likely, says Baird
Baird analyst Peter Benedict kept his Neutral rating and $16 price target on Hibbett Sports ahead of its Q4 earnings, saying indications of improved sector demand and the company's emerging omni-channel capabilities suggest that the comps in the quarter could exceed expectations. The analyst raises his SSS forecast to up 2% from down 0.7%, but warns that material gross margin pressure is likely to constrain earnings. While the stock "looks inexpensive", Benedict believes that a "credible path to stabilize EBIT dollars remains a key hurdle."
03/21/19
CEDG
03/21/19
DOWNGRADE
CEDG
Equal Weight
Hibbett Sports downgraded to Equal Weight from Overweight at Consumer Edge
03/22/19
BARD
03/22/19
NO CHANGE
Target $23
BARD
Neutral
Hibbett Sports price target raised to $23 from $16 at Baird
Baird analyst Peter Benedict said he is incrementally positive on Hibbett Sports following the company's strong finish to the year, though he also noted that its FY19 comparable store sales view was "slightly disappointing." He believes the stock's risk/reward looks "pretty balanced" following today's post-earnings advance and he keeps a Neutral rating on Hibbett shares, though Benedict raised his price target to $23 from $16.

TODAY'S FREE FLY STORIES

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

17:28
12/05/19
12/05
17:28
12/05/19
17:28
Hot Stocks
DocuSign up 8.5% to $75.38 after Q3 results beat estimates »

The company also raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

  • 16

    Dec

DASTY

Dassault Systemes

$0.00

(0.00%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Initiation
Dassault Systemes initiated  »

Dassault Systemes resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Hot Stocks
Ulta Beauty up 10% to $259.20 after Q3 profit beat estimates »

The company also narrowed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AUMN

Golden Minerals

$0.30

0.0089 (3.07%)

17:21
12/05/19
12/05
17:21
12/05/19
17:21
Syndicate
Breaking Syndicate news story on Golden Minerals »

Golden Minerals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$16.62

0.065 (0.39%)

17:18
12/05/19
12/05
17:18
12/05/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Yext »

Yext down 21% to $13.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FIZZ

National Beverage

$48.28

-1.16 (-2.35%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Earnings
National Beverage reports Q2 EPS 70c, consensus 68c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$34.49

1.58 (4.80%)

17:15
12/05/19
12/05
17:15
12/05/19
17:15
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONDS

Ondas Holdings

$0.00

(0.00%)

17:12
12/05/19
12/05
17:12
12/05/19
17:12
Syndicate
Breaking Syndicate news story on Ondas Holdings »

Ondas Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GH

Guardant Health

$73.57

-1.43 (-1.91%)

17:11
12/05/19
12/05
17:11
12/05/19
17:11
Hot Stocks
Guardant Health Chief Medical Officer Richard Lanman to retire »

On December 2, Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$44.13

0.1 (0.23%)

17:10
12/05/19
12/05
17:10
12/05/19
17:10
Hot Stocks
Douglas Emmett raises quarterly dividend by 8% to 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Periodicals
Zoom Video shares fall on moderating revenue growth, CNBC reports »

Zoom's revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 16

    Dec

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

, EIGI

Endurance

$4.04

-0.06 (-1.46%)

17:03
12/05/19
12/05
17:03
12/05/19
17:03
Hot Stocks
TripAdvisor acquires SinglePlatform from Endurance, terms not disclosed »

TripAdvisor (TRIP)…

TRIP

TripAdvisor

$29.04

0.51 (1.79%)

EIGI

Endurance

$4.04

-0.06 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.63

-0.45 (-1.21%)

, COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

16:56
12/05/19
12/05
16:56
12/05/19
16:56
Periodicals
OPEC cancels customary press conference after meeting, CNBC reports »

Amid reports that OPEC…

BP

BP

$36.63

-0.45 (-1.21%)

COP

ConocoPhillips

$59.83

-0.8 (-1.32%)

TOT

Total

$52.29

0.02 (0.04%)

XOM

Exxon Mobil

$68.41

-0.24 (-0.35%)

CVX

Chevron

$116.30

-0.66 (-0.56%)

RDS.A

Royal Dutch Shell

$56.50

-0.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

16:53
12/05/19
12/05
16:53
12/05/19
16:53
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

ESTA

Establishment Labs

$24.31

0.32 (1.33%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Hot Stocks
Establishment Labs reaches one million Motiva implants milestone »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.